0

Close
 
Upcoming Allied Market Research
2023
Neurovascular Guidewires Market

Neurovascular Guidewires Market

by Type (Solid guide wire, Wrapped guide wire), by Material (Stainless steel, Platinum, Palladium, Tungsten, polymer, Others), by Coatings (Lubricious, Dielectric, Hemocompatible) and by Application (Arteriovenous Malformations, Intracranial and Extra-Cranial Angioplasty, Aneurysms, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

MC : Advanced Materials
Report Code: A15747
Nov 2023 | Pages: NA
Tables: NA
Charts: NA

  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.
 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Neurovascular Guidewires Market

Request Now !

Neurovascular guidewires are metallic and non-metallic structures that guide angiographic catheters through blood channels for implantation in cardiology and radiology operations. Neurovascular guidewires are used to place stents or coils in intracranial sites to repair tumors and cerebral arterial anomalies. A tiny incision is used to implant neurovascular guidewires into the patient's body. Neurovascular guidewires come in a variety of shapes and sizes, depending on the use, such as the kidney, liver and heart. The hydrophilic coating, rigidity, low friction navigation, flexibility, and torque ability of neurovascular guidewires all play a part in their utilization during therapy. The growing popularity of minimally invasive surgical over surgical treatment is boosting the use of neurovascular guidewires.

COVID-19 Impact analysis

  • The neurovascular guidewires market was negatively affected due to the outbreak of COVID-19 pandemic.
  • The COVID-19 pandemic has caused the imposition of lockdown due to which the production of neurovascular guidewires decreased and the global supply chain was affected.
  • The neurovascular guidewires market faced downfall of revenue due to the COVID-19 pandemic.

Top Impacting Factors

Due to a variety of factors, the worldwide neurovascular guidewires market is predicted to rise rapidly.

The global neurovascular guidewires market is expected to grow fast due to a number of factors. Minimally invasive procedures are becoming more popular as they offer advantages over open surgeries such as less bleeding, less postoperative infection, fewer problems, a shorter hospital stay, and quicker recovery. The growing demand for enhanced guidewires with better lubrication, simplicity of insertion, and reduced patient discomfort has generated a profitable R&D opportunity in this industry. The rise in frequency of cardiovascular illnesses, growth in the number of interventional diagnostic procedures, surge in demand for minimally invasive surgeries, and advantageous reimbursement scenario are driving the global neurovascular guidewires market. The global neurovascular guidewires market is expected to be hampered by the high cost of minimally invasive operations and difficulties associated with guidewire use.

Market Trends

  • Due to the extreme rising prevalence of neurovascular illnesses in the region, North America dominates and contributes the largest revenue share to the worldwide neurovascular guidewire market. The market is predicted to increase significantly over the forecast period.
  • Europe has also supplied moderate shares to the worldwide neurovascular guidewires market, with a good growth rate, followed by North America.
  • Because of the increasing medical tourism in Asia-Pacific nations such as India, the Asia-Pacific market for neurovascular guidewires has become a viable industry.
  • The Asia-Pacific neurovascular guidewires market is additionally boosted by increased infrastructure expansions and improvements in the medical industry. The global neurovascular guidewires market is in its infancy in Latin America and the Middle East and Africa, but it is predicted to develop moderately over the forecast period due to the region's burgeoning medical industry.
  • Over the projection period, the global neurovascular guidewires market would benefit from R &D initiatives in terms of technology innovation for product improvement by guidewire manufacturing businesses, as well as customization of guidewires based on treatment requirements.

Key Benefits of the Report

  • This study presents the analytical depiction of the neurovascular guidewires industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the neurovascular guidewires market share.
  • The current market is quantitatively analyzed to highlight the neurovascular guidewires market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market. 
  • The report provides a detailed neurovascular guidewires market analysis based on competitive intensity and how the competition will take shape in coming years

 Neurovascular Guidewires Market Report Highlights

Aspects Details
By Type
  • Solid guide wire
  • Wrapped guide wire
By Material
  • Stainless steel
  • Platinum
  • Palladium
  • Tungsten
  • polymer
  • Others
By Coatings
  • Lubricious
    • Hydrophilic
    • Hydrophobic
  • Dielectric
  • Hemocompatible
By Application
  • Arteriovenous Malformations
  • Intracranial and Extra-Cranial Angioplasty
  • Aneurysms
  • Others
By Region
  • Asia-Pacific  (China, India, Japan, South Korea, Rest of Asia-Pacific)
  • North America  (United States, Canada, Mexico)
  • Europe  (Germany, United Kingdom, France, Italy, Rest of Europe)
  • South America  (Brazil, Argentina, Rest of South America)
  • Middle-East and Africa  (Saudi Arabia, South Africa, Rest of Middle-East and Africa)
Key Market Players Acme Monaco, Terumo Corporation, Asahi Intecc, Cardinal Health, Inc., ConMed, Medtronic, St. Jude Medical, Inc., Medtronic, Inc., B. Braun, Cook Medical, Inc., Creganna Medical, Stryker Corporation, Boston Scientific Corporation, Integer Holding Corporation
 

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

    • 3.6. COVID-19 Impact Analysis

  • CHAPTER 4: NEUROVASCULAR GUIDEWIRES MARKET, BY TYPE

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Type

    • 4.2. Solid Guide Wire

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Wrapped Guide Wire

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

  • CHAPTER 5: NEUROVASCULAR GUIDEWIRES MARKET, BY MATERIAL

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Material

    • 5.2. Stainless Steel

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Platinum

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Palladium

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

    • 5.5. Tungsten

      • 5.5.1. Key Market Trends, Growth Factors and Opportunities

      • 5.5.2. Market Size and Forecast, By Region

      • 5.5.3. Market Share Analysis, By Country

    • 5.6. Polymer

      • 5.6.1. Key Market Trends, Growth Factors and Opportunities

      • 5.6.2. Market Size and Forecast, By Region

      • 5.6.3. Market Share Analysis, By Country

    • 5.7. Others

      • 5.7.1. Key Market Trends, Growth Factors and Opportunities

      • 5.7.2. Market Size and Forecast, By Region

      • 5.7.3. Market Share Analysis, By Country

  • CHAPTER 6: NEUROVASCULAR GUIDEWIRES MARKET, BY COATINGS

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Coatings

    • 6.2. Lubricious

      • 6.2.1. Key Market Trends, Growth Factors and Opportunities

      • 6.2.2. Market Size and Forecast, By Region

      • 6.2.3. Market Share Analysis, By Country

      • 6.2.4. Hydrophilic

        • 6.2.4.1. Market Size and Forecast

      • 6.2.4. Hydrophobic

        • 6.2.4.1. Market Size and Forecast

    • 6.3. Dielectric

      • 6.3.1. Key Market Trends, Growth Factors and Opportunities

      • 6.3.2. Market Size and Forecast, By Region

      • 6.3.3. Market Share Analysis, By Country

    • 6.4. Hemocompatible

      • 6.4.1. Key Market Trends, Growth Factors and Opportunities

      • 6.4.2. Market Size and Forecast, By Region

      • 6.4.3. Market Share Analysis, By Country

  • CHAPTER 7: NEUROVASCULAR GUIDEWIRES MARKET, BY APPLICATION

    • 7.1. Market Overview

      • 7.1.1 Market Size and Forecast, By Application

    • 7.2. Arteriovenous Malformations

      • 7.2.1. Key Market Trends, Growth Factors and Opportunities

      • 7.2.2. Market Size and Forecast, By Region

      • 7.2.3. Market Share Analysis, By Country

    • 7.3. Intracranial And Extra-Cranial Angioplasty

      • 7.3.1. Key Market Trends, Growth Factors and Opportunities

      • 7.3.2. Market Size and Forecast, By Region

      • 7.3.3. Market Share Analysis, By Country

    • 7.4. Aneurysms

      • 7.4.1. Key Market Trends, Growth Factors and Opportunities

      • 7.4.2. Market Size and Forecast, By Region

      • 7.4.3. Market Share Analysis, By Country

    • 7.5. Others

      • 7.5.1. Key Market Trends, Growth Factors and Opportunities

      • 7.5.2. Market Size and Forecast, By Region

      • 7.5.3. Market Share Analysis, By Country

  • CHAPTER 8: NEUROVASCULAR GUIDEWIRES MARKET, BY REGION

    • 8.1. Market Overview

      • 8.1.1 Market Size and Forecast, By Region

    • 8.2. North America

      • 8.2.1. Key Market Trends and Opportunities

      • 8.2.2. Market Size and Forecast, By Type

      • 8.2.3. Market Size and Forecast, By Material

      • 8.2.4. Market Size and Forecast, By Coatings

      • 8.2.5. Market Size and Forecast, By Application

      • 8.2.6. Market Size and Forecast, By Country

      • 8.2.7. U.S. Neurovascular Guidewires Market

        • 8.2.7.1. Market Size and Forecast, By Type
        • 8.2.7.2. Market Size and Forecast, By Material
        • 8.2.7.3. Market Size and Forecast, By Coatings
        • 8.2.7.4. Market Size and Forecast, By Application

      • 8.2.8. Canada Neurovascular Guidewires Market

        • 8.2.8.1. Market Size and Forecast, By Type
        • 8.2.8.2. Market Size and Forecast, By Material
        • 8.2.8.3. Market Size and Forecast, By Coatings
        • 8.2.8.4. Market Size and Forecast, By Application

      • 8.2.9. Mexico Neurovascular Guidewires Market

        • 8.2.9.1. Market Size and Forecast, By Type
        • 8.2.9.2. Market Size and Forecast, By Material
        • 8.2.9.3. Market Size and Forecast, By Coatings
        • 8.2.9.4. Market Size and Forecast, By Application

    • 8.3. Europe

      • 8.3.1. Key Market Trends and Opportunities

      • 8.3.2. Market Size and Forecast, By Type

      • 8.3.3. Market Size and Forecast, By Material

      • 8.3.4. Market Size and Forecast, By Coatings

      • 8.3.5. Market Size and Forecast, By Application

      • 8.3.6. Market Size and Forecast, By Country

      • 8.3.7. France Neurovascular Guidewires Market

        • 8.3.7.1. Market Size and Forecast, By Type
        • 8.3.7.2. Market Size and Forecast, By Material
        • 8.3.7.3. Market Size and Forecast, By Coatings
        • 8.3.7.4. Market Size and Forecast, By Application

      • 8.3.8. Germany Neurovascular Guidewires Market

        • 8.3.8.1. Market Size and Forecast, By Type
        • 8.3.8.2. Market Size and Forecast, By Material
        • 8.3.8.3. Market Size and Forecast, By Coatings
        • 8.3.8.4. Market Size and Forecast, By Application

      • 8.3.9. Italy Neurovascular Guidewires Market

        • 8.3.9.1. Market Size and Forecast, By Type
        • 8.3.9.2. Market Size and Forecast, By Material
        • 8.3.9.3. Market Size and Forecast, By Coatings
        • 8.3.9.4. Market Size and Forecast, By Application

      • 8.3.10. Spain Neurovascular Guidewires Market

        • 8.3.10.1. Market Size and Forecast, By Type
        • 8.3.10.2. Market Size and Forecast, By Material
        • 8.3.10.3. Market Size and Forecast, By Coatings
        • 8.3.10.4. Market Size and Forecast, By Application

      • 8.3.11. UK Neurovascular Guidewires Market

        • 8.3.11.1. Market Size and Forecast, By Type
        • 8.3.11.2. Market Size and Forecast, By Material
        • 8.3.11.3. Market Size and Forecast, By Coatings
        • 8.3.11.4. Market Size and Forecast, By Application

      • 8.3.12. Russia Neurovascular Guidewires Market

        • 8.3.12.1. Market Size and Forecast, By Type
        • 8.3.12.2. Market Size and Forecast, By Material
        • 8.3.12.3. Market Size and Forecast, By Coatings
        • 8.3.12.4. Market Size and Forecast, By Application

      • 8.3.13. Rest Of Europe Neurovascular Guidewires Market

        • 8.3.13.1. Market Size and Forecast, By Type
        • 8.3.13.2. Market Size and Forecast, By Material
        • 8.3.13.3. Market Size and Forecast, By Coatings
        • 8.3.13.4. Market Size and Forecast, By Application

    • 8.4. Asia-Pacific

      • 8.4.1. Key Market Trends and Opportunities

      • 8.4.2. Market Size and Forecast, By Type

      • 8.4.3. Market Size and Forecast, By Material

      • 8.4.4. Market Size and Forecast, By Coatings

      • 8.4.5. Market Size and Forecast, By Application

      • 8.4.6. Market Size and Forecast, By Country

      • 8.4.7. China Neurovascular Guidewires Market

        • 8.4.7.1. Market Size and Forecast, By Type
        • 8.4.7.2. Market Size and Forecast, By Material
        • 8.4.7.3. Market Size and Forecast, By Coatings
        • 8.4.7.4. Market Size and Forecast, By Application

      • 8.4.8. Japan Neurovascular Guidewires Market

        • 8.4.8.1. Market Size and Forecast, By Type
        • 8.4.8.2. Market Size and Forecast, By Material
        • 8.4.8.3. Market Size and Forecast, By Coatings
        • 8.4.8.4. Market Size and Forecast, By Application

      • 8.4.9. India Neurovascular Guidewires Market

        • 8.4.9.1. Market Size and Forecast, By Type
        • 8.4.9.2. Market Size and Forecast, By Material
        • 8.4.9.3. Market Size and Forecast, By Coatings
        • 8.4.9.4. Market Size and Forecast, By Application

      • 8.4.10. South Korea Neurovascular Guidewires Market

        • 8.4.10.1. Market Size and Forecast, By Type
        • 8.4.10.2. Market Size and Forecast, By Material
        • 8.4.10.3. Market Size and Forecast, By Coatings
        • 8.4.10.4. Market Size and Forecast, By Application

      • 8.4.11. Australia Neurovascular Guidewires Market

        • 8.4.11.1. Market Size and Forecast, By Type
        • 8.4.11.2. Market Size and Forecast, By Material
        • 8.4.11.3. Market Size and Forecast, By Coatings
        • 8.4.11.4. Market Size and Forecast, By Application

      • 8.4.12. Thailand Neurovascular Guidewires Market

        • 8.4.12.1. Market Size and Forecast, By Type
        • 8.4.12.2. Market Size and Forecast, By Material
        • 8.4.12.3. Market Size and Forecast, By Coatings
        • 8.4.12.4. Market Size and Forecast, By Application

      • 8.4.13. Malaysia Neurovascular Guidewires Market

        • 8.4.13.1. Market Size and Forecast, By Type
        • 8.4.13.2. Market Size and Forecast, By Material
        • 8.4.13.3. Market Size and Forecast, By Coatings
        • 8.4.13.4. Market Size and Forecast, By Application

      • 8.4.14. Indonesia Neurovascular Guidewires Market

        • 8.4.14.1. Market Size and Forecast, By Type
        • 8.4.14.2. Market Size and Forecast, By Material
        • 8.4.14.3. Market Size and Forecast, By Coatings
        • 8.4.14.4. Market Size and Forecast, By Application

      • 8.4.15. Rest of Asia Pacific Neurovascular Guidewires Market

        • 8.4.15.1. Market Size and Forecast, By Type
        • 8.4.15.2. Market Size and Forecast, By Material
        • 8.4.15.3. Market Size and Forecast, By Coatings
        • 8.4.15.4. Market Size and Forecast, By Application

    • 8.5. LAMEA

      • 8.5.1. Key Market Trends and Opportunities

      • 8.5.2. Market Size and Forecast, By Type

      • 8.5.3. Market Size and Forecast, By Material

      • 8.5.4. Market Size and Forecast, By Coatings

      • 8.5.5. Market Size and Forecast, By Application

      • 8.5.6. Market Size and Forecast, By Country

      • 8.5.7. Brazil Neurovascular Guidewires Market

        • 8.5.7.1. Market Size and Forecast, By Type
        • 8.5.7.2. Market Size and Forecast, By Material
        • 8.5.7.3. Market Size and Forecast, By Coatings
        • 8.5.7.4. Market Size and Forecast, By Application

      • 8.5.8. South Africa Neurovascular Guidewires Market

        • 8.5.8.1. Market Size and Forecast, By Type
        • 8.5.8.2. Market Size and Forecast, By Material
        • 8.5.8.3. Market Size and Forecast, By Coatings
        • 8.5.8.4. Market Size and Forecast, By Application

      • 8.5.9. Saudi Arabia Neurovascular Guidewires Market

        • 8.5.9.1. Market Size and Forecast, By Type
        • 8.5.9.2. Market Size and Forecast, By Material
        • 8.5.9.3. Market Size and Forecast, By Coatings
        • 8.5.9.4. Market Size and Forecast, By Application

      • 8.5.10. UAE Neurovascular Guidewires Market

        • 8.5.10.1. Market Size and Forecast, By Type
        • 8.5.10.2. Market Size and Forecast, By Material
        • 8.5.10.3. Market Size and Forecast, By Coatings
        • 8.5.10.4. Market Size and Forecast, By Application

      • 8.5.11. Argentina Neurovascular Guidewires Market

        • 8.5.11.1. Market Size and Forecast, By Type
        • 8.5.11.2. Market Size and Forecast, By Material
        • 8.5.11.3. Market Size and Forecast, By Coatings
        • 8.5.11.4. Market Size and Forecast, By Application

      • 8.5.12. Rest of LAMEA Neurovascular Guidewires Market

        • 8.5.12.1. Market Size and Forecast, By Type
        • 8.5.12.2. Market Size and Forecast, By Material
        • 8.5.12.3. Market Size and Forecast, By Coatings
        • 8.5.12.4. Market Size and Forecast, By Application

  • CHAPTER 9: COMPETITIVE LANDSCAPE

    • 9.1. Introduction

    • 9.2. Top Winning Strategies

    • 9.3. Product Mapping Of Top 10 Player

    • 9.4. Competitive Dashboard

    • 9.5. Competitive Heatmap

    • 9.6. Top Player Positioning,2022

  • CHAPTER 10: COMPANY PROFILES

    • 10.1. St. Jude Medical, Inc.

      • 10.1.1. Company Overview

      • 10.1.2. Key Executives

      • 10.1.3. Company Snapshot

      • 10.1.4. Operating Business Segments

      • 10.1.5. Product Portfolio

      • 10.1.6. Business Performance

      • 10.1.7. Key Strategic Moves and Developments

    • 10.2. B. Braun, Cook Medical, Inc.

      • 10.2.1. Company Overview

      • 10.2.2. Key Executives

      • 10.2.3. Company Snapshot

      • 10.2.4. Operating Business Segments

      • 10.2.5. Product Portfolio

      • 10.2.6. Business Performance

      • 10.2.7. Key Strategic Moves and Developments

    • 10.3. Creganna Medical

      • 10.3.1. Company Overview

      • 10.3.2. Key Executives

      • 10.3.3. Company Snapshot

      • 10.3.4. Operating Business Segments

      • 10.3.5. Product Portfolio

      • 10.3.6. Business Performance

      • 10.3.7. Key Strategic Moves and Developments

    • 10.4. Medtronic

      • 10.4.1. Company Overview

      • 10.4.2. Key Executives

      • 10.4.3. Company Snapshot

      • 10.4.4. Operating Business Segments

      • 10.4.5. Product Portfolio

      • 10.4.6. Business Performance

      • 10.4.7. Key Strategic Moves and Developments

    • 10.5. Asahi Intecc

      • 10.5.1. Company Overview

      • 10.5.2. Key Executives

      • 10.5.3. Company Snapshot

      • 10.5.4. Operating Business Segments

      • 10.5.5. Product Portfolio

      • 10.5.6. Business Performance

      • 10.5.7. Key Strategic Moves and Developments

    • 10.6. Medtronic, Inc.

      • 10.6.1. Company Overview

      • 10.6.2. Key Executives

      • 10.6.3. Company Snapshot

      • 10.6.4. Operating Business Segments

      • 10.6.5. Product Portfolio

      • 10.6.6. Business Performance

      • 10.6.7. Key Strategic Moves and Developments

    • 10.7. Boston Scientific Corporation

      • 10.7.1. Company Overview

      • 10.7.2. Key Executives

      • 10.7.3. Company Snapshot

      • 10.7.4. Operating Business Segments

      • 10.7.5. Product Portfolio

      • 10.7.6. Business Performance

      • 10.7.7. Key Strategic Moves and Developments

    • 10.8. Integer Holding Corporation

      • 10.8.1. Company Overview

      • 10.8.2. Key Executives

      • 10.8.3. Company Snapshot

      • 10.8.4. Operating Business Segments

      • 10.8.5. Product Portfolio

      • 10.8.6. Business Performance

      • 10.8.7. Key Strategic Moves and Developments

    • 10.9. Stryker Corporation

      • 10.9.1. Company Overview

      • 10.9.2. Key Executives

      • 10.9.3. Company Snapshot

      • 10.9.4. Operating Business Segments

      • 10.9.5. Product Portfolio

      • 10.9.6. Business Performance

      • 10.9.7. Key Strategic Moves and Developments

    • 10.10. ConMed

      • 10.10.1. Company Overview

      • 10.10.2. Key Executives

      • 10.10.3. Company Snapshot

      • 10.10.4. Operating Business Segments

      • 10.10.5. Product Portfolio

      • 10.10.6. Business Performance

      • 10.10.7. Key Strategic Moves and Developments

    • 10.11. Terumo Corporation

      • 10.11.1. Company Overview

      • 10.11.2. Key Executives

      • 10.11.3. Company Snapshot

      • 10.11.4. Operating Business Segments

      • 10.11.5. Product Portfolio

      • 10.11.6. Business Performance

      • 10.11.7. Key Strategic Moves and Developments

    • 10.12. Cardinal Health, Inc.

      • 10.12.1. Company Overview

      • 10.12.2. Key Executives

      • 10.12.3. Company Snapshot

      • 10.12.4. Operating Business Segments

      • 10.12.5. Product Portfolio

      • 10.12.6. Business Performance

      • 10.12.7. Key Strategic Moves and Developments

    • 10.13. Acme Monaco

      • 10.13.1. Company Overview

      • 10.13.2. Key Executives

      • 10.13.3. Company Snapshot

      • 10.13.4. Operating Business Segments

      • 10.13.5. Product Portfolio

      • 10.13.6. Business Performance

      • 10.13.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL NEUROVASCULAR GUIDEWIRES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 2. GLOBAL NEUROVASCULAR GUIDEWIRES MARKET FOR SOLID GUIDE WIRE, BY REGION, 2022-2032 ($MILLION)
  • TABLE 3. GLOBAL NEUROVASCULAR GUIDEWIRES MARKET FOR WRAPPED GUIDE WIRE, BY REGION, 2022-2032 ($MILLION)
  • TABLE 4. GLOBAL NEUROVASCULAR GUIDEWIRES MARKET, BY MATERIAL, 2022-2032 ($MILLION)
  • TABLE 5. GLOBAL NEUROVASCULAR GUIDEWIRES MARKET FOR STAINLESS STEEL, BY REGION, 2022-2032 ($MILLION)
  • TABLE 6. GLOBAL NEUROVASCULAR GUIDEWIRES MARKET FOR PLATINUM, BY REGION, 2022-2032 ($MILLION)
  • TABLE 7. GLOBAL NEUROVASCULAR GUIDEWIRES MARKET FOR PALLADIUM, BY REGION, 2022-2032 ($MILLION)
  • TABLE 8. GLOBAL NEUROVASCULAR GUIDEWIRES MARKET FOR TUNGSTEN, BY REGION, 2022-2032 ($MILLION)
  • TABLE 9. GLOBAL NEUROVASCULAR GUIDEWIRES MARKET FOR POLYMER, BY REGION, 2022-2032 ($MILLION)
  • TABLE 10. GLOBAL NEUROVASCULAR GUIDEWIRES MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 11. GLOBAL NEUROVASCULAR GUIDEWIRES MARKET, BY COATINGS, 2022-2032 ($MILLION)
  • TABLE 12. GLOBAL NEUROVASCULAR GUIDEWIRES MARKET FOR LUBRICIOUS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 13. GLOBAL NEUROVASCULAR GUIDEWIRES MARKET FOR DIELECTRIC, BY REGION, 2022-2032 ($MILLION)
  • TABLE 14. GLOBAL NEUROVASCULAR GUIDEWIRES MARKET FOR HEMOCOMPATIBLE, BY REGION, 2022-2032 ($MILLION)
  • TABLE 15. GLOBAL NEUROVASCULAR GUIDEWIRES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 16. GLOBAL NEUROVASCULAR GUIDEWIRES MARKET FOR ARTERIOVENOUS MALFORMATIONS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 17. GLOBAL NEUROVASCULAR GUIDEWIRES MARKET FOR INTRACRANIAL AND EXTRA-CRANIAL ANGIOPLASTY, BY REGION, 2022-2032 ($MILLION)
  • TABLE 18. GLOBAL NEUROVASCULAR GUIDEWIRES MARKET FOR ANEURYSMS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 19. GLOBAL NEUROVASCULAR GUIDEWIRES MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 20. GLOBAL NEUROVASCULAR GUIDEWIRES MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 21. NORTH AMERICA NEUROVASCULAR GUIDEWIRES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 22. NORTH AMERICA NEUROVASCULAR GUIDEWIRES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 23. NORTH AMERICA NEUROVASCULAR GUIDEWIRES, BY MATERIAL, 2022-2032 ($MILLION)
  • TABLE 24. NORTH AMERICA NEUROVASCULAR GUIDEWIRES, BY COATINGS, 2022-2032 ($MILLION)
  • TABLE 25. NORTH AMERICA NEUROVASCULAR GUIDEWIRES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 26. U.S. NEUROVASCULAR GUIDEWIRES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 27. U.S. NEUROVASCULAR GUIDEWIRES, BY MATERIAL, 2022-2032 ($MILLION)
  • TABLE 28. U.S. NEUROVASCULAR GUIDEWIRES, BY COATINGS, 2022-2032 ($MILLION)
  • TABLE 29. U.S. NEUROVASCULAR GUIDEWIRES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 30. CANADA NEUROVASCULAR GUIDEWIRES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 31. CANADA NEUROVASCULAR GUIDEWIRES, BY MATERIAL, 2022-2032 ($MILLION)
  • TABLE 32. CANADA NEUROVASCULAR GUIDEWIRES, BY COATINGS, 2022-2032 ($MILLION)
  • TABLE 33. CANADA NEUROVASCULAR GUIDEWIRES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 34. MEXICO NEUROVASCULAR GUIDEWIRES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 35. MEXICO NEUROVASCULAR GUIDEWIRES, BY MATERIAL, 2022-2032 ($MILLION)
  • TABLE 36. MEXICO NEUROVASCULAR GUIDEWIRES, BY COATINGS, 2022-2032 ($MILLION)
  • TABLE 37. MEXICO NEUROVASCULAR GUIDEWIRES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 38. EUROPE NEUROVASCULAR GUIDEWIRES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 39. EUROPE NEUROVASCULAR GUIDEWIRES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 40. EUROPE NEUROVASCULAR GUIDEWIRES, BY MATERIAL, 2022-2032 ($MILLION)
  • TABLE 41. EUROPE NEUROVASCULAR GUIDEWIRES, BY COATINGS, 2022-2032 ($MILLION)
  • TABLE 42. EUROPE NEUROVASCULAR GUIDEWIRES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 43. FRANCE NEUROVASCULAR GUIDEWIRES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 44. FRANCE NEUROVASCULAR GUIDEWIRES, BY MATERIAL, 2022-2032 ($MILLION)
  • TABLE 45. FRANCE NEUROVASCULAR GUIDEWIRES, BY COATINGS, 2022-2032 ($MILLION)
  • TABLE 46. FRANCE NEUROVASCULAR GUIDEWIRES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 47. GERMANY NEUROVASCULAR GUIDEWIRES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 48. GERMANY NEUROVASCULAR GUIDEWIRES, BY MATERIAL, 2022-2032 ($MILLION)
  • TABLE 49. GERMANY NEUROVASCULAR GUIDEWIRES, BY COATINGS, 2022-2032 ($MILLION)
  • TABLE 50. GERMANY NEUROVASCULAR GUIDEWIRES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 51. ITALY NEUROVASCULAR GUIDEWIRES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 52. ITALY NEUROVASCULAR GUIDEWIRES, BY MATERIAL, 2022-2032 ($MILLION)
  • TABLE 53. ITALY NEUROVASCULAR GUIDEWIRES, BY COATINGS, 2022-2032 ($MILLION)
  • TABLE 54. ITALY NEUROVASCULAR GUIDEWIRES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 55. SPAIN NEUROVASCULAR GUIDEWIRES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 56. SPAIN NEUROVASCULAR GUIDEWIRES, BY MATERIAL, 2022-2032 ($MILLION)
  • TABLE 57. SPAIN NEUROVASCULAR GUIDEWIRES, BY COATINGS, 2022-2032 ($MILLION)
  • TABLE 58. SPAIN NEUROVASCULAR GUIDEWIRES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 59. UK NEUROVASCULAR GUIDEWIRES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 60. UK NEUROVASCULAR GUIDEWIRES, BY MATERIAL, 2022-2032 ($MILLION)
  • TABLE 61. UK NEUROVASCULAR GUIDEWIRES, BY COATINGS, 2022-2032 ($MILLION)
  • TABLE 62. UK NEUROVASCULAR GUIDEWIRES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 63. RUSSIA NEUROVASCULAR GUIDEWIRES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 64. RUSSIA NEUROVASCULAR GUIDEWIRES, BY MATERIAL, 2022-2032 ($MILLION)
  • TABLE 65. RUSSIA NEUROVASCULAR GUIDEWIRES, BY COATINGS, 2022-2032 ($MILLION)
  • TABLE 66. RUSSIA NEUROVASCULAR GUIDEWIRES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 67. REST OF EUROPE NEUROVASCULAR GUIDEWIRES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 68. REST OF EUROPE NEUROVASCULAR GUIDEWIRES, BY MATERIAL, 2022-2032 ($MILLION)
  • TABLE 69. REST OF EUROPE NEUROVASCULAR GUIDEWIRES, BY COATINGS, 2022-2032 ($MILLION)
  • TABLE 70. REST OF EUROPE NEUROVASCULAR GUIDEWIRES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 71. ASIA-PACIFIC NEUROVASCULAR GUIDEWIRES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 72. ASIA-PACIFIC NEUROVASCULAR GUIDEWIRES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 73. ASIA-PACIFIC NEUROVASCULAR GUIDEWIRES, BY MATERIAL, 2022-2032 ($MILLION)
  • TABLE 74. ASIA-PACIFIC NEUROVASCULAR GUIDEWIRES, BY COATINGS, 2022-2032 ($MILLION)
  • TABLE 75. ASIA-PACIFIC NEUROVASCULAR GUIDEWIRES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 76. CHINA NEUROVASCULAR GUIDEWIRES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 77. CHINA NEUROVASCULAR GUIDEWIRES, BY MATERIAL, 2022-2032 ($MILLION)
  • TABLE 78. CHINA NEUROVASCULAR GUIDEWIRES, BY COATINGS, 2022-2032 ($MILLION)
  • TABLE 79. CHINA NEUROVASCULAR GUIDEWIRES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 80. JAPAN NEUROVASCULAR GUIDEWIRES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 81. JAPAN NEUROVASCULAR GUIDEWIRES, BY MATERIAL, 2022-2032 ($MILLION)
  • TABLE 82. JAPAN NEUROVASCULAR GUIDEWIRES, BY COATINGS, 2022-2032 ($MILLION)
  • TABLE 83. JAPAN NEUROVASCULAR GUIDEWIRES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 84. INDIA NEUROVASCULAR GUIDEWIRES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 85. INDIA NEUROVASCULAR GUIDEWIRES, BY MATERIAL, 2022-2032 ($MILLION)
  • TABLE 86. INDIA NEUROVASCULAR GUIDEWIRES, BY COATINGS, 2022-2032 ($MILLION)
  • TABLE 87. INDIA NEUROVASCULAR GUIDEWIRES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 88. SOUTH KOREA NEUROVASCULAR GUIDEWIRES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 89. SOUTH KOREA NEUROVASCULAR GUIDEWIRES, BY MATERIAL, 2022-2032 ($MILLION)
  • TABLE 90. SOUTH KOREA NEUROVASCULAR GUIDEWIRES, BY COATINGS, 2022-2032 ($MILLION)
  • TABLE 91. SOUTH KOREA NEUROVASCULAR GUIDEWIRES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 92. AUSTRALIA NEUROVASCULAR GUIDEWIRES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 93. AUSTRALIA NEUROVASCULAR GUIDEWIRES, BY MATERIAL, 2022-2032 ($MILLION)
  • TABLE 94. AUSTRALIA NEUROVASCULAR GUIDEWIRES, BY COATINGS, 2022-2032 ($MILLION)
  • TABLE 95. AUSTRALIA NEUROVASCULAR GUIDEWIRES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 96. THAILAND NEUROVASCULAR GUIDEWIRES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 97. THAILAND NEUROVASCULAR GUIDEWIRES, BY MATERIAL, 2022-2032 ($MILLION)
  • TABLE 98. THAILAND NEUROVASCULAR GUIDEWIRES, BY COATINGS, 2022-2032 ($MILLION)
  • TABLE 99. THAILAND NEUROVASCULAR GUIDEWIRES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 100. MALAYSIA NEUROVASCULAR GUIDEWIRES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 101. MALAYSIA NEUROVASCULAR GUIDEWIRES, BY MATERIAL, 2022-2032 ($MILLION)
  • TABLE 102. MALAYSIA NEUROVASCULAR GUIDEWIRES, BY COATINGS, 2022-2032 ($MILLION)
  • TABLE 103. MALAYSIA NEUROVASCULAR GUIDEWIRES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 104. INDONESIA NEUROVASCULAR GUIDEWIRES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 105. INDONESIA NEUROVASCULAR GUIDEWIRES, BY MATERIAL, 2022-2032 ($MILLION)
  • TABLE 106. INDONESIA NEUROVASCULAR GUIDEWIRES, BY COATINGS, 2022-2032 ($MILLION)
  • TABLE 107. INDONESIA NEUROVASCULAR GUIDEWIRES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 108. REST OF ASIA PACIFIC NEUROVASCULAR GUIDEWIRES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 109. REST OF ASIA PACIFIC NEUROVASCULAR GUIDEWIRES, BY MATERIAL, 2022-2032 ($MILLION)
  • TABLE 110. REST OF ASIA PACIFIC NEUROVASCULAR GUIDEWIRES, BY COATINGS, 2022-2032 ($MILLION)
  • TABLE 111. REST OF ASIA PACIFIC NEUROVASCULAR GUIDEWIRES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 112. LAMEA NEUROVASCULAR GUIDEWIRES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 113. LAMEA NEUROVASCULAR GUIDEWIRES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 114. LAMEA NEUROVASCULAR GUIDEWIRES, BY MATERIAL, 2022-2032 ($MILLION)
  • TABLE 115. LAMEA NEUROVASCULAR GUIDEWIRES, BY COATINGS, 2022-2032 ($MILLION)
  • TABLE 116. LAMEA NEUROVASCULAR GUIDEWIRES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 117. BRAZIL NEUROVASCULAR GUIDEWIRES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 118. BRAZIL NEUROVASCULAR GUIDEWIRES, BY MATERIAL, 2022-2032 ($MILLION)
  • TABLE 119. BRAZIL NEUROVASCULAR GUIDEWIRES, BY COATINGS, 2022-2032 ($MILLION)
  • TABLE 120. BRAZIL NEUROVASCULAR GUIDEWIRES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 121. SOUTH AFRICA NEUROVASCULAR GUIDEWIRES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 122. SOUTH AFRICA NEUROVASCULAR GUIDEWIRES, BY MATERIAL, 2022-2032 ($MILLION)
  • TABLE 123. SOUTH AFRICA NEUROVASCULAR GUIDEWIRES, BY COATINGS, 2022-2032 ($MILLION)
  • TABLE 124. SOUTH AFRICA NEUROVASCULAR GUIDEWIRES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 125. SAUDI ARABIA NEUROVASCULAR GUIDEWIRES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 126. SAUDI ARABIA NEUROVASCULAR GUIDEWIRES, BY MATERIAL, 2022-2032 ($MILLION)
  • TABLE 127. SAUDI ARABIA NEUROVASCULAR GUIDEWIRES, BY COATINGS, 2022-2032 ($MILLION)
  • TABLE 128. SAUDI ARABIA NEUROVASCULAR GUIDEWIRES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 129. UAE NEUROVASCULAR GUIDEWIRES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 130. UAE NEUROVASCULAR GUIDEWIRES, BY MATERIAL, 2022-2032 ($MILLION)
  • TABLE 131. UAE NEUROVASCULAR GUIDEWIRES, BY COATINGS, 2022-2032 ($MILLION)
  • TABLE 132. UAE NEUROVASCULAR GUIDEWIRES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 133. ARGENTINA NEUROVASCULAR GUIDEWIRES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 134. ARGENTINA NEUROVASCULAR GUIDEWIRES, BY MATERIAL, 2022-2032 ($MILLION)
  • TABLE 135. ARGENTINA NEUROVASCULAR GUIDEWIRES, BY COATINGS, 2022-2032 ($MILLION)
  • TABLE 136. ARGENTINA NEUROVASCULAR GUIDEWIRES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 137. REST OF LAMEA NEUROVASCULAR GUIDEWIRES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 138. REST OF LAMEA NEUROVASCULAR GUIDEWIRES, BY MATERIAL, 2022-2032 ($MILLION)
  • TABLE 139. REST OF LAMEA NEUROVASCULAR GUIDEWIRES, BY COATINGS, 2022-2032 ($MILLION)
  • TABLE 140. REST OF LAMEA NEUROVASCULAR GUIDEWIRES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 141. ST. JUDE MEDICAL, INC.: KEY EXECUTIVES
  • TABLE 142. ST. JUDE MEDICAL, INC.: COMPANY SNAPSHOT
  • TABLE 143. ST. JUDE MEDICAL, INC.: OPERATING SEGMENTS
  • TABLE 144. ST. JUDE MEDICAL, INC.: PRODUCT PORTFOLIO
  • TABLE 145. ST. JUDE MEDICAL, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 146. B. BRAUN, COOK MEDICAL, INC.: KEY EXECUTIVES
  • TABLE 147. B. BRAUN, COOK MEDICAL, INC.: COMPANY SNAPSHOT
  • TABLE 148. B. BRAUN, COOK MEDICAL, INC.: OPERATING SEGMENTS
  • TABLE 149. B. BRAUN, COOK MEDICAL, INC.: PRODUCT PORTFOLIO
  • TABLE 150. B. BRAUN, COOK MEDICAL, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 151. CREGANNA MEDICAL: KEY EXECUTIVES
  • TABLE 152. CREGANNA MEDICAL: COMPANY SNAPSHOT
  • TABLE 153. CREGANNA MEDICAL: OPERATING SEGMENTS
  • TABLE 154. CREGANNA MEDICAL: PRODUCT PORTFOLIO
  • TABLE 155. CREGANNA MEDICAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 156. MEDTRONIC: KEY EXECUTIVES
  • TABLE 157. MEDTRONIC: COMPANY SNAPSHOT
  • TABLE 158. MEDTRONIC: OPERATING SEGMENTS
  • TABLE 159. MEDTRONIC: PRODUCT PORTFOLIO
  • TABLE 160. MEDTRONIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 161. ASAHI INTECC: KEY EXECUTIVES
  • TABLE 162. ASAHI INTECC: COMPANY SNAPSHOT
  • TABLE 163. ASAHI INTECC: OPERATING SEGMENTS
  • TABLE 164. ASAHI INTECC: PRODUCT PORTFOLIO
  • TABLE 165. ASAHI INTECC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 166. MEDTRONIC, INC.: KEY EXECUTIVES
  • TABLE 167. MEDTRONIC, INC.: COMPANY SNAPSHOT
  • TABLE 168. MEDTRONIC, INC.: OPERATING SEGMENTS
  • TABLE 169. MEDTRONIC, INC.: PRODUCT PORTFOLIO
  • TABLE 170. MEDTRONIC, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 171. BOSTON SCIENTIFIC CORPORATION: KEY EXECUTIVES
  • TABLE 172. BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
  • TABLE 173. BOSTON SCIENTIFIC CORPORATION: OPERATING SEGMENTS
  • TABLE 174. BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
  • TABLE 175. BOSTON SCIENTIFIC CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 176. INTEGER HOLDING CORPORATION: KEY EXECUTIVES
  • TABLE 177. INTEGER HOLDING CORPORATION: COMPANY SNAPSHOT
  • TABLE 178. INTEGER HOLDING CORPORATION: OPERATING SEGMENTS
  • TABLE 179. INTEGER HOLDING CORPORATION: PRODUCT PORTFOLIO
  • TABLE 180. INTEGER HOLDING CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 181. STRYKER CORPORATION: KEY EXECUTIVES
  • TABLE 182. STRYKER CORPORATION: COMPANY SNAPSHOT
  • TABLE 183. STRYKER CORPORATION: OPERATING SEGMENTS
  • TABLE 184. STRYKER CORPORATION: PRODUCT PORTFOLIO
  • TABLE 185. STRYKER CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 186. CONMED: KEY EXECUTIVES
  • TABLE 187. CONMED: COMPANY SNAPSHOT
  • TABLE 188. CONMED: OPERATING SEGMENTS
  • TABLE 189. CONMED: PRODUCT PORTFOLIO
  • TABLE 190. CONMED: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 191. TERUMO CORPORATION: KEY EXECUTIVES
  • TABLE 192. TERUMO CORPORATION: COMPANY SNAPSHOT
  • TABLE 193. TERUMO CORPORATION: OPERATING SEGMENTS
  • TABLE 194. TERUMO CORPORATION: PRODUCT PORTFOLIO
  • TABLE 195. TERUMO CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 196. CARDINAL HEALTH, INC.: KEY EXECUTIVES
  • TABLE 197. CARDINAL HEALTH, INC.: COMPANY SNAPSHOT
  • TABLE 198. CARDINAL HEALTH, INC.: OPERATING SEGMENTS
  • TABLE 199. CARDINAL HEALTH, INC.: PRODUCT PORTFOLIO
  • TABLE 200. CARDINAL HEALTH, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 201. ACME MONACO: KEY EXECUTIVES
  • TABLE 202. ACME MONACO: COMPANY SNAPSHOT
  • TABLE 203. ACME MONACO: OPERATING SEGMENTS
  • TABLE 204. ACME MONACO: PRODUCT PORTFOLIO
  • TABLE 205. ACME MONACO: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL NEUROVASCULAR GUIDEWIRES MARKET SEGMENTATION
  • FIGURE 2. GLOBAL NEUROVASCULAR GUIDEWIRES MARKET
  • FIGURE 3. SEGMENTATION NEUROVASCULAR GUIDEWIRES MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN NEUROVASCULAR GUIDEWIRES MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALNEUROVASCULAR GUIDEWIRES MARKET
  • FIGURE 11. NEUROVASCULAR GUIDEWIRES MARKET SEGMENTATION, BY BY TYPE
  • FIGURE 12. NEUROVASCULAR GUIDEWIRES MARKET FOR SOLID GUIDE WIRE, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 13. NEUROVASCULAR GUIDEWIRES MARKET FOR WRAPPED GUIDE WIRE, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 14. NEUROVASCULAR GUIDEWIRES MARKET SEGMENTATION, BY BY MATERIAL
  • FIGURE 15. NEUROVASCULAR GUIDEWIRES MARKET FOR STAINLESS STEEL, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 16. NEUROVASCULAR GUIDEWIRES MARKET FOR PLATINUM, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 17. NEUROVASCULAR GUIDEWIRES MARKET FOR PALLADIUM, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 18. NEUROVASCULAR GUIDEWIRES MARKET FOR TUNGSTEN, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 19. NEUROVASCULAR GUIDEWIRES MARKET FOR POLYMER, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 20. NEUROVASCULAR GUIDEWIRES MARKET FOR OTHERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 21. NEUROVASCULAR GUIDEWIRES MARKET SEGMENTATION, BY BY COATINGS
  • FIGURE 22. NEUROVASCULAR GUIDEWIRES MARKET FOR LUBRICIOUS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 23. NEUROVASCULAR GUIDEWIRES MARKET FOR DIELECTRIC, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 24. NEUROVASCULAR GUIDEWIRES MARKET FOR HEMOCOMPATIBLE, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 25. NEUROVASCULAR GUIDEWIRES MARKET SEGMENTATION, BY BY APPLICATION
  • FIGURE 26. NEUROVASCULAR GUIDEWIRES MARKET FOR ARTERIOVENOUS MALFORMATIONS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 27. NEUROVASCULAR GUIDEWIRES MARKET FOR INTRACRANIAL AND EXTRA-CRANIAL ANGIOPLASTY, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 28. NEUROVASCULAR GUIDEWIRES MARKET FOR ANEURYSMS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 29. NEUROVASCULAR GUIDEWIRES MARKET FOR OTHERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 30. TOP WINNING STRATEGIES, BY YEAR, 2020-2022*
  • FIGURE 31. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2020-2022*
  • FIGURE 32. TOP WINNING STRATEGIES, BY COMPANY, 2020-2022*
  • FIGURE 33. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 34. COMPETITIVE DASHBOARD
  • FIGURE 35. COMPETITIVE HEATMAP: NEUROVASCULAR GUIDEWIRES MARKET
  • FIGURE 36. Top player positioning, 2022
  • FIGURE 37. ST. JUDE MEDICAL, INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 38. ST. JUDE MEDICAL, INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 39. ST. JUDE MEDICAL, INC.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 40. B. BRAUN, COOK MEDICAL, INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 41. B. BRAUN, COOK MEDICAL, INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 42. B. BRAUN, COOK MEDICAL, INC.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 43. CREGANNA MEDICAL: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 44. CREGANNA MEDICAL: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 45. CREGANNA MEDICAL: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 46. MEDTRONIC: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 47. MEDTRONIC: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 48. MEDTRONIC: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 49. ASAHI INTECC: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 50. ASAHI INTECC: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 51. ASAHI INTECC: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 52. MEDTRONIC, INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 53. MEDTRONIC, INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 54. MEDTRONIC, INC.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 55. BOSTON SCIENTIFIC CORPORATION: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 56. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 57. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 58. INTEGER HOLDING CORPORATION: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 59. INTEGER HOLDING CORPORATION: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 60. INTEGER HOLDING CORPORATION: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 61. STRYKER CORPORATION: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 62. STRYKER CORPORATION: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 63. STRYKER CORPORATION: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 64. CONMED: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 65. CONMED: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 66. CONMED: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 67. TERUMO CORPORATION: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 68. TERUMO CORPORATION: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 69. TERUMO CORPORATION: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 70. CARDINAL HEALTH, INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 71. CARDINAL HEALTH, INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 72. CARDINAL HEALTH, INC.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 73. ACME MONACO: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 74. ACME MONACO: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 75. ACME MONACO: REVENUE SHARE, BY REGION, 2032 (%)

 
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now

Purchase Full Report of
Neurovascular Guidewires Market

Start reading.
This Report and over 66,804+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,930
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Enterprise
    License/PDF

  • $9,870
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers